Why this portfolio manager rates Walgreens a buy

Tony Scherrer, director of research and portfolio manager at Smead Capital Management, joins "Squawk Box" to explain why he's highlighting three very different types of companies: a homebuilder, a mall operator and a drug store chain.
Thu, Nov 7 20198:44 AM EST